Back
ATH
Description
Description
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. The company is headquartered in Melbourne, Victoria and currently employs 9 full-time employees. The company went IPO on 2000-03-28. The firm is focused on developing disease modifying treatments for neurodegenerative diseases. The firm's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company has the potential to treat Parkinson's disease,...
Show more
ASX
Biotechnology
Performance
Performance
$0.01
AUD
▼ -$0.13 (-93.33%)
30th November 2025, 12:00 a.m.
1M
1Y
10Y
GRAPH
TABLE
GRAPH
TABLE
Quick facts
Quick facts
▼ -14.71% Growth
5 year average annual growth
N/A
5 year average dividend yield
$ 500 minimum investment
Due to regulatory requirements
$410.93 median portfolio
Median amount held by the community
Costs
Costs
PURCHASE FEE
$6.50 AUD (or $5.50 with Pearler Prepay)
MANAGEMENT FEE
N/A
ESG
ESG
55.37
Environmental score
74.39
Social score
31.43
Governance score
Community insights
Community insights
General statistics
4 investors hold ATH
20 weeks average time between investments
$1,311 average holding per investor
28 days since last community investment
Demographics
Income of investors
50k - 100k
60%
Less than 50k
20%
100k - 150k
20%
150k - 200k
0%
More than 200k
0%
Age of investors
35-90 years old
75%
18-25 years old
25%
26-34 years old
0%
Legal gender of investors
50% male
50% female
Related items
Related items
Pricing data reflects the most recent end-of-day traded price. Live pricing is shown at the time of buy/sell and may differ from what's displayed here. Other data is provided by our data partner, last updated on Tue Nov 25 2025, and may have changed since.
Learn more
Learn more
The history of Berkshire Hathaway: how Warren Buffett's company became a household name
READ
Long Term Investing
Find out how Warren Buffett took Berkshire Hathaway from a struggling textile mill to one of the world’s biggest compani...
20 November 2024
・
Nick Nicolaides
・
5 min read
0 likes
・
7 views
Core-satellite approach vs value investing: which is the right strategy for me?
READ
Long Term Investing
Balance, flexibility, or patience? Discover what core-satellite and value investing offer, and choose the path that alig...
14 November 2024
・
Oyelola Oyetunji
・
7 min read
0 likes
・
10 views
The Aussie FIRE Audiobook | Conclusion
LISTEN
Congratulations! You've made it to the final chapter of our original Aussie FIRE audiobook. In each chapter, we've cover...
Fri, 3rd November 2023
・
8 min
・
0 likes
Episode 0. Welcome to the Aussie FIRE podcast
LISTEN
Welcome to Aussie FIRE, the podcast designed to educate and inspire you towards a better future! This podcast evolved fr...
Fri, 24th November 2023
・
30 min
・
2 likes
US ETFs vs AU ETFs
ASK & ANSWER
Investing Strategy
Are there any downsides to choosing US ETFs over AU ones? Some of the US ETFs outperform AU ones, but as an Australian c...
Stephanie Conroy
•
April 3rd, 2024
0 likes
・
119 views
・
AU vs US shares
ASK & ANSWER
First Time Investor
Hi, I’m fairly new to investing and this is a dumb question but what is the difference when investing in the AU shares v...
Molly Pearse
•
January 29th, 2023
5 likes
・
74 views
・
What’s happened to my shares and it’s value if I suddenly die
ASK & ANSWER
Investing Strategy
Hi, I just started my investment with ASX last month. But I started worrying and wanted to know what’s happened to my sh...
Ngoc Nguyen
•
September 30th, 2022
2 likes
・
88 views
・